Articles

Future of Non-personal Promotional in Pharma

Compelling messaging is at the core of every effective pharmaceutical marketing strategy. Whether it is the launch of a new drug or a message refresh project, crisp copy that builds an emotional connection with your target market can help keep communication impactful, without making it highly complex or over-simplistic. 

Many pharmaceutical companies produce large amounts of unremarkable copy which doesn’t convert. To help you cut through the noise of communication of rival pharma companies, Newristics has created the Ultimate Pharma Messaging Guide with 20 guiding principles that have been scientifically proven to turbocharge pharma communications. 


Ultimate Pharma Messaging Guidebook

Genetic Insights for Biopharmaceuticals: Propelling Drug Candidates Into Therapeutic Assets (Mar 2023)

In this application note you will learn the importance of reproducible gene expression quantitation to evaluate host immune response for optimizing safety of gene therapies.

Importance of Data Reproducibility for Development of Safe Gene Therapies

When a company reaches late-stages of clinical trials testing new drugs, systems need to be created to manage the manufacturing, sales, costs, internal controls, and more. A successful transition into commercializing a new drug depends on putting in place the right infrastructure and systems.

Cloud ERP to Support Commercial Readiness

Readily available real-world data and advanced solutions are being used to stitch together the full patient journey, and these longitudinal insights are being used to identify and characterize trial populations and inform clinical trial design and execution strategies.

Leveraging Real-World Patient Journeys at Scale for Clinical Trial Strategies

IT Leaders in Life Sciences discuss the consolidation of the learning tech environment to help shift the training effectiveness conversation from anecdotal evidence to data-driven understanding.



Consolidating your Learning Tech Environment

In today’s hypercompetitive pharmaceutical and life sciences (PLS) industry, strategic partnerships are more critical than ever. While these third-party relationships can be full of risk and regulatory challenges, the right tech can help you navigate the complexities of compliance.



How purpose-built tech can help pharmaceutical and life science companies streamline healthcare provider interactions

When the regulatory hammer came down on pharmaceutical and life sciences (PLS) companies in the 2010s, new systems were quickly — and possibly haphazardly — put in place to handle snowballing transparency reporting requirements. Now the cracks are beginning to show, and PLS companies are realizing the true cost of transparency reporting. 

Understanding the true cost of transparency reporting

Digital health platforms, modern delivery models, and edge technologies can transform the way life sciences companies create a virtuous circle of value generation, equipping patients with capabilities that improve health outcomes while providing businesses with valuable data and insights to drive new research, improve stakeholders’ experiences, and accelerate growth. Solutions designed to serve clinical trial participants outside of a clinical setting should be considered as companion services for commercial therapies to drive greater adherence as well as real-world evidence.



All Whitepapers